1. When Using DOPPS Slides

2. DOPPS Slide Use Guidelines

3. International Trends in Erythropoietin Use and Hemoglobin Levels in Hemodialysis Patients

4. Introduction

5. DOPPS Background (1)

6. DOPPS Background (2)

7. Methods (1)

8. Methods (2)

9. Methods (3)

10. Table 1: Selected demographic parameters among DOPPS countries (1)

11. Table 1: Selected demographic parameters among DOPPS countries (2)

12. Table 1: Selected demographic parameters among DOPPS countries (3)

14. Table 1: Selected demographic parameters among DOPPS countries (5)

15. Table 2: Changes in mean Hgb levels and % of patients with Hgb level above 12.0 g/dL (1)

16. Table 2: Changes in mean Hgb levels and % of patients with Hgb level above 12.0 g/dL (2)

17. Figure 1: Mean ESA dose and Hgb level

18. Table 3: Changes in mean ESA dose (1)

19. Table 3: Changes in mean ESA dose (2)

20. Table 4: Changes in percentage of patients with mean ESA dose greater than 35,000 U/week a

21. Table 5: Changes in mean monthly intravenous iron dose (mg/month)

22. Table 6: Changes in median hemoglobin levels and median ESA dose (1)

23. Table 6: Changes in median hemoglobin levels and median ESA dose (2)

24. Table 7: Answers from DOPPS III Questionnaire Anemia Management Section

25. Figure 2: Hemoglobin target range for adult hemodialysis patients on an ESA

26. Conclusions

27. Acknowledgements